MKC-442
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MKC-442, covering 2008-08-14 to 2008-08-14. Get the full timeline:
Most recent: Clinical Trial Update: The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors [Phase 2]